If indeed it is at NIH expense.
And MSB have final say to proceed of not on good interim results.
Then let trial run to completion.
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-217
-
- There are more pages in this discussion • 229 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.025(2.55%) |
Mkt cap ! $1.150B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 99.0¢ | $3.427M | 3.413M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 71593 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 141955 | 24 |
View Market Depth
| Last trade - 14.20pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |